Back to Trades
Sell4
PTC THERAPEUTICS, INC.
PTCT
Total Value
$609.1K
Net $279.6K sold
Sales
$279.6K
4 transactions
Company Information
- Company Name
- PTC THERAPEUTICS, INC.
- Ticker Symbol
- PTCT
- CIK
- 0001070081
Insider Information
- Role
- Insider
- Location
- WARREN, NJ
Filing Details
- Filing Date
- May 12, 2026
- Transaction Date
- May 8, 2026
- Accession Number
- 0001578852-26-000014
- Form Type
- 4
- Net Trading Amount
- -$279.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | 2,740 | $46.54 | Exercise | $127.5K |
| May 8, 2026 | Common Stock | 840 | $78.23 | Sale | $65.7K |
| May 8, 2026 | Common Stock | 1,900 | $79.31 | Sale | $150.7K |
| May 8, 2026 | Common Stock | 800 | $46.54 | Exercise | $37.2K |
| May 8, 2026 | Common Stock | 200 | $78.00 | Sale | $15.6K |
| May 8, 2026 | Common Stock | 600 | $79.28 | Sale | $47.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 8, 2026 | Derivative | 2,740 | $46.54 | Exercise | $127.5K |
| May 8, 2026 | Derivative | 800 | $46.54 | Exercise | $37.2K |
Footnotes
- (F1)This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.
- (F2)This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F3)This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.03 to $79.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F4)This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.02 to $79.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F5)This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.